| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1200/JCO.2007.11.3183 |
| P8608 | Fatcat ID | release_ybqqmnbh5natfmhiswns3lm4ry |
| P698 | PubMed publication ID | 17991925 |
| P50 | author | Andrew Bottomley | Q66812411 |
| P2093 | author name string | Neil K Aaronson | |
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | quality of life | Q13100823 |
| P304 | page(s) | 5082-6 | |
| P577 | publication date | 2007-11-10 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience | |
| P478 | volume | 25 |
| Q92326880 | A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study |
| Q38789975 | A large scale prospective clinical and psychometric validation of the EORTC colorectal (QLQ-CR29) module in Polish patients with colorectal cancer. |
| Q38732038 | A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. |
| Q47619222 | A systematic review and development of a classification framework for factors associated with missing patient-reported outcome data |
| Q37729195 | Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG. |
| Q47644799 | Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials |
| Q44896541 | Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia |
| Q35670334 | Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders |
| Q48027758 | Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes |
| Q34993621 | Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review. |
| Q34262449 | DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct |
| Q55438987 | Danish translation and pilot testing of the European Organization for Research and Treatment of Cancer QLQ-TC 26 (EORTC QLQ-TC26) questionnaire to assess health-related quality of life in patients with testicular cancer. |
| Q34174380 | Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea |
| Q53134306 | Enhancing patient-reported outcome measurement in research and practice of palliative and end-of-life care. |
| Q34035015 | Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data |
| Q39061576 | Group medical consultations in the follow-up of breast cancer: a randomized feasibility study |
| Q34001845 | Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial |
| Q35151555 | Health-related quality of life after cystectomy and urinary diversion for bladder cancer |
| Q42262252 | Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial |
| Q41701973 | Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization f |
| Q36906183 | High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling |
| Q48215849 | High level of distress in long-term survivors of thyroid carcinoma: results of rapid screening using the distress thermometer. |
| Q89777472 | Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study |
| Q88566955 | Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada |
| Q48565555 | Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients |
| Q37383022 | Measuring outcomes in oncology treatment: the importance of patient-centered outcomes |
| Q40139758 | More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling |
| Q44220426 | Patient experiences with gene panels based on exome sequencing in clinical diagnostics: high acceptance and low distress |
| Q89553736 | Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial |
| Q30234561 | Quality of Life Measurements: Any Value for Clinical Practice? |
| Q28655361 | Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials |
| Q37158501 | Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment |
| Q36680034 | Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial |
| Q38053978 | Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer |
| Q48171518 | Testing the measurement equivalence of paper and interactive voice response system versions of the EORTC QLQ-C30. |
| Q64328574 | The Quality of Life and Degree of Depression of Patients Suffering from Breast Cancer |
| Q34095808 | Towards the Implementation of Quality of Life Monitoring in Daily Clinical Routine: Methodological Issues and Clinical Implication |
| Q39257066 | Transdermal buprenorphine for the treatment of cancer pain: results from a multicenter, observational, post-marketing study in Spain (RELIEF study). |
| Q92313117 | Translation and cultural adaptation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Lung Cancer Module for quality of life assessment in patients with lung cancer in Brazil |
| Q92618056 | Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy - PIPAC-OPC2 |
| Q44485496 | Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases |
| Q48185503 | Validation of the Polish version of the EORTC QLQ-CX24 module for the assessment of health-related quality of life in women with cervical cancer |
| Q48112495 | Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer |
| Q34168198 | When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trial |
Search more.